Loading provider…
Loading provider…
Nephrology Physician in New York, NY
NPI: 1275605446Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Trustees of Columbia University in the City of New York
columbiadoctors.org
HQ Phone
Get M.D. Jai's Phone Numberphone_androidMobile
Get M.D. Jai's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2021
NJ State Medical License
2021 - 2027
NY State Medical License
1994 - 2026
CT State Medical License
2022 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
Mailman School of Public Health, Columbia University
MS • Biostatistics
Until 2005
New York Presbyterian Hospital (Columbia Campus)
Fellowship • Nephrology
1990 - 1994
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital
Fellowship • Nephrology
1990 - 1991
Lincoln Medical and Mental Health Center
Residency • Internal Medicine
1988 - 1990
Jawaharlal Institute of Postgraduate Medical Education and Research
Medical School
Until 1984
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 176 | 469 |
| 2 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 66 | 211 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 61 | 134 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 35 | 40 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 27 | 27 |
Letter to the EditorThe Authors Reply
Authors: Kenar Jhaveri, Sumit Mohan, Sandra Amaral, Miguel Valderrabano, Danai Kitkungvan, Roham Zamanian, Nihal Bakeer, Dipan Shah, Fernando Fervenza, Kathleen Liu, Jeffrey Towbin, Mark Haas
Journal: Crit Care Med
Publication Date: 2022-05-19
Lead Sponsor: Bayer
Intervention / Treatment: DRUG: Placebo, DRUG: Finerenone (BAY94-8862)
Lead Sponsor: Mayo Clinic
Collaborators: Stanford University, University of Alabama at Birmingham, University of Michigan, Columbia University, The Cleveland Clinic, Medical College of Wisconsin, Case Western Reserve University, University Health Network, Toronto, University of Washington, Washington University School of Medicine, University of British Columbia, University of Toronto, University of Mississippi Medical Center, Ohio State University, NYU Langone Health, University of Kansas Medical Center, Sunnybrook Health Sciences Centre, University of Manchester, CHU de Quebec-Universite Laval, Florida International University, University of Arizona, Applied Health Research Centre, Fulk Family Foundation
Intervention / Treatment: DRUG: Rituximab, DRUG: Cyclosporine
Lead Sponsor: Travere Therapeutics, Inc.
Intervention / Treatment: DRUG: Irbesartan, DRUG: RE-021 (Sparsentan)